Mumbai : Biocon is currently trading at Rs. 620.60, up by 0.50 points or 0.08% from its previous closing of Rs. 620.10 on the BSE. The scrip opened at Rs. 629.00 and has touched a high and low of Rs. 629.00 and Rs. 612.70 respectively. So far 199932 shares were traded on the counter. The BSE group ‘A’ stock of face value Rs. 5 has touched a 52 week high of Rs. 718.35 on 26-Sep-2018 and a 52 week low of Rs. 543.80 on 26-Jul-2018.
Last one week high and low of the scrip stood at Rs. 629.00 and Rs. 606.00 respectively. The current market cap of the company is Rs. 37194.00 crore. The promoters holding in the company stood at 60.67%, while Institutions and Non-Institutions held 22.28% and 17.05% respectively.
Biocon has reported a fall of 1.95% in its net profit at Rs 70.50 crore for the quarter ended March 31, 2019 as compared to Rs 71.90 crore for the same quarter in the previous year. Total income of the company increased by 14.50% at Rs 777.80 crore for quarter under review as compared to Rs 679.30 crore for the quarter ended March 31, 2018.
On consolidated basis, the company has reported rise of 63.88% in its net profit at Rs 213.70 crore for the quarter ended March 31, 2019 as compared to Rs 130.40 crore for the corresponding quarter in the FY18. Total consolidated income of the company rose 25.87% at Rs 1,557.00 crore for quarter under review as compared to Rs 1,237.00 crore for the same quarter ended previous year.
For the year ended March 31, 2019, the company has posted a 2-fold jump in its net profit at Rs 492.70 crore as compared to Rs 238.50 crore for the previous year. Total income of company increased 17.72% at Rs 3,002.20 crore for year under review as compared to Rs 2,550.20 crore for year ended March 31, 2018.
For the year ended March 31, 2019, on the consolidated basis, the company has posted 2-fold jump in its net profit at Rs 905.30 crore as compared to Rs 372.40 crore for the previous year. Total income of company increased by 30.51% at Rs 5,658.80 crore for year under review as compared to Rs 4,335.90 crore for year ended March 31, 2018.
The post Biocon rises on reporting 64% jump in Q4 consolidated net profit appeared first on Udaipur News | Udaipur Latest News | udaipur local news.
